Evidence map›Paper›PMID 39388396›Full record

ArticlePloS one2024

A search for bacteria identified from cerebrospinal fluid shunt infections in previous surgical events.

Paul Hodor, Christopher E Pope, Kathryn B Whitlock, Patrick J McDonald, Jason Hauptman, Lucas R Hoffman, David D Limbrick, Tamara D Simon, Cerebrospinal FLuId MicroBiota in Shunts (CLIMB) Study Group

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paul HodorAurynia LLC, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0001-7770-8347
Christopher E PopeDepartment of Pediatrics, University of Washington, Seattle, Washington, United States of America.
Kathryn B WhitlockNew Harmony Statistical Consulting LLC, Clinton, Washington, United States of America.
Patrick J McDonaldSection of Neurosurgery, University of Manitoba, Winnipeg, Manitoba, Canada.
Jason HauptmanSeattle Children's Research Institute, Seattle, Washington, United States of America.
Lucas R HoffmanDepartment of Pediatrics, University of Washington, Seattle, Washington, United States of America.
David D LimbrickDepartment of Neurosurgery, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Tamara D SimonDepartment of Pediatrics, University of Southern California, Los Angeles, California, United States of America.
Cerebrospinal FLuId MicroBiota in Shunts (CLIMB) Study Group

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI PRADEEP k SINGH · 2010 to 2026
$21.4M
Targeting the CSF microbiota to optimize CSF shunt infection treatmentR01NS095979 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI SIMON, TAMARA DANIELLE · 2016 to 2020
$2.0M
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric diseaseK24HL141669 · NHLBI · UNIVERSITY OF WASHINGTON · PI Lucas R Hoffman · 2018 to 2026
$929k
NCATS NIH HHS UL1 TR001855NHLBI NIH HHS K24 HL141669NIDDK NIH HHS P30 DK089507NINDS NIH HHS R01 NS095979
6 · The paper itself

Abstract

Shunt infections are a common complication when treating hydrocephalus by cerebrospinal fluid (CSF) shunt placement. The source of infecting pathogens is not well understood. One hypothesis, which we explored here, is that microorganisms persist chronically in the host long before a symptomatic infection occurs and may be detectable in surgical events preceding infection. A cohort of 13 patients was selected, for which CSF samples were available from an infection episode and from a previous surgery event, which was either an initial shunt placement or a revision. Microbiota were analyzed both directly from CSF and from isolates cultured from CSF on aerobic and anaerobic media. The detection and identification of bacteria was done with high throughput DNA sequencing methods and mass spectrometry. The presence of bacteria was confirmed in 4 infection samples, of which 2 were after initial placement and 2 after revision surgery. Taxonomic identification was consistent with clinical microbiology laboratory results. Bacteria were not detected in any of the CSF samples collected at the time of the previous surgical events. While our findings do not provide direct evidence for long-term persistence of pathogens, they suggest the need for consideration of additional source material, such as biofilm and environmental swabs, and/or the use of more sensitive and specific analytical methods.

Indexed as

BacteriaCerebrospinal Fluid ShuntsHydrocephalusAdultAgedBacterial InfectionsFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle Aged

Identifiers

PMID39388396
PMCPMC11469614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.